Operating Company Business Services

Nexus Health

Stamford, Connecticut, United States

Nexus Health is a market access consultancy and part of The Lockwood Group. It provides pharmaceutical and biotechnology clients with services across coverage, pricing and reimbursement, trade and distribution, patient services, evidence planning and generation, value communications, payer marketing, data and analytics, and policy and advocacy. Its 2026 acquisition of Stratis Group expanded its commercialization strategy, analytics, and patient support capabilities.

Focus Areas
Life sciences market access consulting, Commercialization strategy, Coverage, pricing and reimbursement advisory

Tracked deals

3

3 tracked deals across 2022-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

2 buyout · 1 addon

Nexus Health Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Nexus Health. 1 2022 1 2025 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Nexus Health, part of The Lockwood Group, The Lockwood Group, LLC, Ares Management Corporation
    Target
    Stratis Group, LLC
    Type
    Addon

    Nexus Health, part of The Lockwood Group, acquired Stratis Group, a commercialization strategy and market access consulting firm for pharmaceutical, biotechnology, and physician network clients. The deal expands Nexus Health’s integrated, data-driven capabilities across patient services, HEOR, real-world evidence, adherence strategy, and field reimbursement management.

  • Buyer
    The Lockwood Group
    Target
    Research To Practice
    Type
    Buyout

    The Lockwood Group has acquired Research To Practice (RTP), a Miami-based provider of accredited oncology-focused medical education. The acquisition expands The Lockwood Group's healthcare services platform capabilities in oncology education, continuing medical education formats, and global clinical insights.

  • Buyer
    The Lockwood Group
    Target
    Random42
    Seller
    Graphite Capital
    Location
    England, United Kingdom
    Type
    Buyout

    The Lockwood Group, a Stamford-based medical communications agency, has acquired Random42, a London-based medical animation and scientific communications studio, from private equity firm Graphite Capital. The acquisition expands Lockwood's creative capabilities (animation, VR/AR, interactive experiences) and extends Random42's geographic footprint, particularly into the U.S. market.

Related Acquisition Pages

Selling a company? Get in front of buyers like Nexus Health

Turn tracked acquisition activity into an outreach-ready buyer list.